Pasmant E - Search Results

1

The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.

Beinse G, Just PA, Rance B, Izac B, Letourneur F, Saidu NEB, Chouzenoux S, Nicco C, Goldwasser F, Pasmant E, Batteux F, Borghese B, Alexandre J, Leroy K. Beinse G, et al. Among authors: pasmant e. PLoS One. 2019 Mar 25;14(3):e0214416. doi: 10.1371/journal.pone.0214416. eCollection 2019. PLoS One. 2019. PMID: 30908539 Free PMC article.

2

Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.

Pasmant E, Ortonne N, Rittié L, Laurendeau I, Lévy P, Lazar V, Parfait B, Leroy K, Dessen P, Valeyrie-Allanore L, Perbal B, Wolkenstein P, Vidaud M, Vidaud D, Bièche I. Pasmant E, et al. J Neuropathol Exp Neurol. 2010 Jan;69(1):60-9. doi: 10.1097/NEN.0b013e3181c79bff. J Neuropathol Exp Neurol. 2010. PMID: 20010302

3

Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients.

Pasmant E, Masliah-Planchon J, Lévy P, Laurendeau I, Ortonne N, Parfait B, Valeyrie-Allanore L, Leroy K, Wolkenstein P, Vidaud M, Vidaud D, Bièche I. Pasmant E, et al. Mol Med. 2011 Jan-Feb;17(1-2):79-87. doi: 10.2119/molmed.2010.00079. Epub 2010 Sep 10. Mol Med. 2011. PMID: 20844836 Free PMC article.

4

MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis.

Masliah-Planchon J, Pasmant E, Luscan A, Laurendeau I, Ortonne N, Hivelin M, Varin J, Valeyrie-Allanore L, Dumaine V, Lantieri L, Leroy K, Parfait B, Wolkenstein P, Vidaud M, Vidaud D, Bièche I. Masliah-Planchon J, et al. Among authors: pasmant e. BMC Genomics. 2013 Jul 13;14:473. doi: 10.1186/1471-2164-14-473. BMC Genomics. 2013. PMID: 23848554 Free PMC article.

5

The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.

Luscan A, Shackleford G, Masliah-Planchon J, Laurendeau I, Ortonne N, Varin J, Lallemand F, Leroy K, Dumaine V, Hivelin M, Borderie D, De Raedt T, Valeyrie-Allanore L, Larousserie F, Terris B, Lantieri L, Vidaud M, Vidaud D, Wolkenstein P, Parfait B, Bièche I, Massaad C, Pasmant E. Luscan A, et al. Among authors: pasmant e. Clin Cancer Res. 2014 Jan 15;20(2):358-71. doi: 10.1158/1078-0432.CCR-13-0780. Epub 2013 Nov 11. Clin Cancer Res. 2014. PMID: 24218515

6

Immunohistochemistry versus next-generation sequencing for the routine detection of BRAF V600E mutation in melanomas.

Just PA, Audebourg A, Pasmant E, Clauser E, Carlotti A, Laurent S, Avril MF, Vacher-Lavenu MC, Vidaud M, Terris B. Just PA, et al. Among authors: pasmant e. Hum Pathol. 2014 Sep;45(9):1983-4. doi: 10.1016/j.humpath.2014.05.017. Epub 2014 Jun 18. Hum Pathol. 2014. PMID: 25074543 No abstract available.

7

Uveal melanoma hepatic metastases mutation spectrum analysis using targeted next-generation sequencing of 400 cancer genes.

Luscan A, Just PA, Briand A, Burin des Roziers C, Goussard P, Nitschké P, Vidaud M, Avril MF, Terris B, Pasmant E. Luscan A, et al. Among authors: pasmant e. Br J Ophthalmol. 2015 Apr;99(4):437-9. doi: 10.1136/bjophthalmol-2014-305371. Epub 2014 Oct 31. Br J Ophthalmol. 2015. PMID: 25361747

8

High specificity and sensitivity of NRAS Q61R immunohistochemistry (IHC) in melanomas.

Just PA, Pouliquen C, Audebourg A, Laurent-Roussel S, Carlotti A, Dupin N, Vacher-Lavenu MC, Vidaud M, Terris B, Pasmant E. Just PA, et al. Among authors: pasmant e. J Am Acad Dermatol. 2016 Mar;74(3):572-3. doi: 10.1016/j.jaad.2015.11.011. J Am Acad Dermatol. 2016. PMID: 26892658 No abstract available.

9

Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.

Just PA, Letourneur F, Pouliquen C, Dome F, Audebourg A, Biquet P, Vidaud M, Terris B, Sibony M, Pasmant E. Just PA, et al. Among authors: pasmant e. Genes Chromosomes Cancer. 2016 Jun;55(6):541-8. doi: 10.1002/gcc.22356. Epub 2016 Apr 7. Genes Chromosomes Cancer. 2016. PMID: 26998913

10

Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?

Garinet S, Néou M, de La Villéon B, Faillot S, Sakat J, Da Fonseca JP, Jouinot A, Le Tourneau C, Kamal M, Luscap-Rondof W, Boeva V, Gaujoux S, Vidaud M, Pasmant E, Letourneur F, Bertherat J, Assié G. Garinet S, et al. Among authors: pasmant e. J Mol Diagn. 2017 Sep;19(5):776-787. doi: 10.1016/j.jmoldx.2017.06.005. J Mol Diagn. 2017. PMID: 28826610 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page